A breakthrough in gene therapy for Huntington's disease has been reported, with some outlets suggesting it may slow the disease's progression by a significant amount. However, experts are urging caution, citing potential ethical questions and uncertainty about the treatment's success. The extent of the breakthrough's impact and its potential for further development, including a possible phase 3 trial, remains unclear.